Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (6) Arrow Down
Filter Results: (6) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (24)
    • Faculty Publications  (6)

    Show Results For

    • All HBS Web  (24)
      • Faculty Publications  (6)

      Alzheimer's DiseaseRemove Alzheimer's Disease →

      Page 1 of 6 Results

      Are you looking for?

      →Search All HBS Web
      • July 2024
      • Case

      Gates Ventures: Making Alzheimer's a Forgotten Past

      By: Satish Tadikonda, William Marks, Shardule Shah and Calvin Marambo
      After a personal journey and interest in Alzheimer's Disease (AD) by Bill Gates, Gates Ventures set out to find the best way to accelerate innovation in the field of AD. In partnership with the Alzheimer's Drug Discovery Foundation, Gates Ventures created the... View Details
      Keywords: Philanthropy and Charitable Giving; Entrepreneurial Finance; Health Disorders; Mission and Purpose
      Citation
      Educators
      Purchase
      Related
      Tadikonda, Satish, William Marks, Shardule Shah, and Calvin Marambo. "Gates Ventures: Making Alzheimer's a Forgotten Past." Harvard Business School Case 824-075, July 2024.
      • June 2023 (Revised July 2024)
      • Case

      Biogen and the Aduhelm Melee

      By: Amitabh Chandra and Lauren Gunasti
      Alzheimer's Disease is a devastating condition affecting millions of Americans. At this time, there is no cure. In 2021, Biogen's Aduhelm (aducanumab) received FDA approval under the accelerated approval pathway after a controversial approval process.

      This... View Details
      Keywords: Health Testing and Trials; Governing Rules, Regulations, and Reforms; Valuation; Product Development; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Chandra, Amitabh, and Lauren Gunasti. "Biogen and the Aduhelm Melee." Harvard Business School Case 623-046, June 2023. (Revised July 2024.)
      • 2020
      • Working Paper

      What Can Economics Say About Alzheimer's Disease?

      By: Amitabh Chandra, Courtney Coile and Corina Mommaerts
      Alzheimer’s Disease (AD) affects one in ten people aged 65 or older and is the most expensive disease in the United States. We describe the central economic questions raised by AD. While there is overlap with the economics of aging, the defining features of the... View Details
      Keywords: Health Disorders; Health Care and Treatment; Economics
      Citation
      Read Now
      Related
      Chandra, Amitabh, Courtney Coile, and Corina Mommaerts. "What Can Economics Say About Alzheimer's Disease?" NBER Working Paper Series, No. 27760, August 2020.
      • May 2017
      • Teaching Plan

      Neurotrack and the Alzheimer's Puzzle

      By: Richard G. Hamermesh and Carin-Isabel Knoop
      Teaching Note for HBS No. 816-072. View Details
      Keywords: Health Care; Alzheimer's Disease; Career Path; Life Science Business
      Citation
      Purchase
      Related
      Hamermesh, Richard G., and Carin-Isabel Knoop. "Neurotrack and the Alzheimer's Puzzle." Harvard Business School Teaching Plan 817-140, May 2017.
      • February 2016 (Revised September 2017)
      • Case

      Neurotrack and the Alzheimer's Puzzle

      By: Richard G. Hamermesh, Liz Kind and Carin-Isabel Knoop
      Elli Kaplan founded Neurotrack in 2012 with a breakthrough noninvasive cognitive diagnostics test that will detect Alzheimer's disease in its earliest pre-symptomatic stages. While the company has gained great traction in the three years since it was started, with no... View Details
      Keywords: Alzheimer's Disease; Diagnostics; Healthcare; Entrepreneurship; Health Disorders; Science-Based Business; Business Model; Medical Devices and Supplies Industry; United States
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard G., Liz Kind, and Carin-Isabel Knoop. "Neurotrack and the Alzheimer's Puzzle." Harvard Business School Case 816-072, February 2016. (Revised September 2017.)
      • October 2014 (Revised September 2017)
      • Case

      The National Football League and Brain Injuries

      By: Richard G. Hamermesh and Matthew G. Preble
      The National Football League (NFL) was both the most popular spectator sport in the U.S. and a major economic entity, taking in roughly $10 billion a year in revenue. However through the early twenty-first century, an increased understanding of the long-term effects of... View Details
      Keywords: Employee Safety; Safety; Employees; Sports; Health; Ethics; Sports Industry; United States
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard G., and Matthew G. Preble. "The National Football League and Brain Injuries." Harvard Business School Case 815-071, October 2014. (Revised September 2017.)
      • 1

      Are you looking for?

      →Search All HBS Web
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.